Revvity Hypoxisense 680 Fluoresc

Revvity Hypoxia Occurs In Tumors As A Result Of The Poor Ability Of Their Disorganized Vascular Networks To Deliver Blood Borne Oxygen. Hypoxisense680 Fluorescent Imaging Agent Detects The Tumor Cell Surface Expression Of Carbonic Anhydrase 9 (Ca Ix) Protein, Which Increases In Hypoxic Regions Within Many Tumors, Especially In Cervical, Colorectal, Non-Small Cell Lung Tumors. Pairing Hypoxisense With Optical Fluorescent Imaging Technology Allows You To Image And Quantitate Tumor Sub-Regions Undergoing Hypoxia-Related Changes, Non-Invasively And In Vivo. Hypoxisense In Vivo Imaging Reagent Is Ideally Suited For Detecting Hypoxia-Induced Changes In Ca Ix Expression During: Imaging In Vivo Mouse And Rat Tumors Assessing Therapeutic Efficacy In Drug Screening Of Tumor Models Fluorescence Microscopy Of Disease Tissues For The First Time, Hypoxia Can Be Measured Non-Invasively In Living Mice And Rats, As Well As In Ex Vivo Tissue Samples. Its The Perfect Solution For The In Vivo Hypoxia Researcher - PEGSK (Additional S&H Or Hazmat Fees May Apply)